1/27
Comprehensive flashcards covering cardiac medications including antihypertensives, diuretics, antianginals, and antilipemics from the lecture transcript.
ACE Inhibitors
Angiotensin Converting Enzyme inhibitors that end in -pril (e.g., lisinopril, enalapril) and block the conversion of angiotensin I to angiotensin II.
ACE Adverse Effects
Commonly described by the 'ACE' mnemonic: Angioedema, Cough (persistent non-protective), and Elevated potassium (hyperkalemia).
ARBs
Angiotensin II Receptor Blockers that end in -sartan (e.g., valsartan, losartan) and selectively block the binding of angiotensin II to AT1 receptors.
Aliskiren
A Direct Renin Inhibitor that binds with renin to inhibit the production of angiotensin I; levels are increased by atorvastatin and decreased by high-fat meals.
Loop Diuretics
Medications ending in -ide (e.g., furosemide, bumetanide) that work in the loop of Henle to block reabsorption of sodium, chloride, and water.
Ototoxicity
A specific adverse effect of loop diuretics (like furosemide) that involves hearing impairment; it is notably NOT a risk with thiazide diuretics.
Thiazide Diuretics
Medications ending in -thiazide that block sodium and chloride absorption in the distal convoluted tubule; often the first medication used for essential HTN.
Potassium Sparing Diuretics
Medications like spironolactone and triamterene that block aldosterone, resulting in potassium retention and excretion of sodium and water.
Mannitol
An IV Osmotic Diuretic used to reduce intracranial and intraocular pressure by raising serum osmolarity.
Calcium Channel Blockers
Medications ending in -zem or -dipine that slow calcium entry into smooth-muscle cells, causing arterial dilation; grapefruit juice causes toxic effects with these meds.
Alpha Adrenergic Blockers
Medications ending in -zosin (e.g., prazosin) that inhibit alpha 1 receptors to cause peripheral arterial and venous dilation.
Alpha 2 Agonists
Centrally acting medications like clonidine and methyldopa that reduce peripheral vascular resistance and HR; can cause rebound HTN 48 hours after discontinuation.
Beta Blockers
Medications ending in -lol that decrease cardiac excitability and output; nonselective types (e.g., propranolol) are contraindicated for asthmatics.
Vasodilators
Medications such as nitroprusside and hydralazine that rapidly reduce BP; nitroprusside use carries a risk of cyanide and thiocyanate poisoning.
Nitroglycerine Administration
For acute chest pain, take 1 tablet sublingually every 5 minutes for a maximum of 3 tablets; call 911 if unrelieved after the first tablet.
Ranolazine
A prolonged-release antianginal that lowers cardiac oxygen demand; it can cause a prolonged QT interval (torsades).
Digoxin
A Cardiac Glycoside that increases the force of myocardial contractions and slows conduction rate to allow increased ventricular filling.
Digoxin Toxicity
Occurs at serum levels above 2.0ng/mL; symptoms include anorexia, nausea, fatigue, and yellow-green or white halos around objects.
Digoxin Immune FAB
The specific antidote used to manage digoxin toxicity and prevent further absorption.
Adenosine
An antidysrhythmic that restores NSR by slowing conduction through the AV node; must be given as a rapid IV push (1−2 seconds) due to a short half-life.
Amiodarone
An antidysrhythmic that prolongs repolarization and relaxes smooth muscle for V-fib or unstable V-tach; it is incompatible with heparin.
Atropine
A medication that increases heart rate by counteracting muscarine-like actions of acetylcholine; used for bradycardia.
Adrenergic Agonists
Vasopressors like epinephrine and dopamine that treat hypotension through vasoconstriction and increase myocardial contractility.
Statins
Antilipemic medications (e.g., atorvastatin) that interfere with hepatic enzyme HMG COA to reduce cholesterol; should be taken in the evening.
Ezetimibe
A Cholesterol Absorption Inhibitor that inhibits absorption of cholesterol from food and bile; do not take at the same time as other antilipemics.
Bile-Acid Sequestrants
Medications like colesevelam that decrease LDL; a common adverse effect is constipation, requiring increased fluid and fiber intake.
Fibrates
Medications like gemfibrozil that reduce plasma triglycerides and increase HDL; patients should monitor for RUQ pain or jaundice (hepatotoxicity).
Monoclonal Antibodies
Injectable antilipemics like alirocumab and evolocumab that decrease LDL by binding to LDL receptors.